Your browser doesn't support javascript.
loading
Development of Anterior Segment Focused Biologic Therapies to Regenerate Corneal Tissue for the Treatment of Disease: Drug Development Experience.
Rowe-Rendleman, Cheryl; Eveleth, David; Goldberg, Jeffrey L; Jurkunas, Ula; Okumura, Naoki; Dawson, Daniel; Sawant, Onkar B.
Affiliation
  • Rowe-Rendleman C; Omar Consulting Group, LLC, Durham, North Carolina, USA.
  • Eveleth D; Trefoil Therapeutics, San Diego, California, USA.
  • Goldberg JL; Byers Eye Institute, Stanford University, Stanford, California, USA.
  • Jurkunas U; Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
  • Okumura N; Doshisha University, Kyotanabe, Japan.
  • Dawson D; University of Florida, Gainesville, Florida, USA.
  • Sawant OB; Center for Vision and Eye Banking Research, Eversight, Cleveland, Ohio, USA.
J Ocul Pharmacol Ther ; 39(8): 551-562, 2023 10.
Article in En | MEDLINE | ID: mdl-37733302
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cornea / Regenerative Medicine Language: En Journal: J Ocul Pharmacol Ther Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cornea / Regenerative Medicine Language: En Journal: J Ocul Pharmacol Ther Year: 2023 Type: Article Affiliation country: United States